Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Bangkok Dusit Medical Services (BDMS TB)
Watchlist
225
Analysis
Health Care
•
Thailand
Bangkok Dusit Medical Services Public Company Limited operates Bangkok General Hospital. The Hospital specializes in cardiovascular, lung, neurological, eye and genitourinary cancer, as well as physical therapy and medical imaging.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Bangkok Dusit Medical Services
•
18 Sep 2024 18:34
•
Broker
Bangkok Dusit Medical Services - Expected Earnings Peak in 3Q24E Already Priced In
We initiate coverage on BDMS with a Neutral rating and a 12- month fair value (12M FV) of Bt28.75, based on the earnings yield method with a...
Krungthai XSpring
Follow
155 Views
Share
bullish
•
Bangkok Dusit Medical Services
•
18 Nov 2023 23:38
Bangkok Dusit Medical Services (BDMS TB): Highest Ever Quarterly Sales in 3Q; 2023 Guidance Raised
Bangkok Dusit Medical clocked 11% YoY revenue growth in Q3, driven by international and Thai patients, leading to an upward revision of 2023...
Tina Banerjee
Follow
424 Views
Share
bullish
•
Bangkok Dusit Medical Services
•
20 May 2024 01:14
Bangkok Dusit Medical Services (BDMS TB): Thai and International Patients Drives 1Q24 Result
Bangkok Dusit Medical sees double-digit revenue growth in 1Q24, driven by international and Thai patients, amid healthy occupancy. New cancer care...
Tina Banerjee
Follow
307 Views
Share
bullish
•
Bangkok Dusit Medical Services
•
23 Feb 2024 09:30
Bangkok Dusit Medical Services (BDMS TB): Core Business Drives 4Q23 Result; Outlook Remains Positive
BDMS sees double-digit growth in 4Q23 driven by international and Thai non-COVID patient revenues. The company is expecting continued growth in...
Tina Banerjee
Follow
402 Views
Share
bullish
•
IHH Healthcare
•
03 Dec 2023 22:49
IHH Healthcare (IHH MK): Double-Digit Growth Across Key Metrics for Q3; Bed Expansion to Continue
IHH reported stellar performance in 3Q23, with 19% revenue and 26% EBITDA growth on higher patient volumes and improved case mix. The company plans...
Tina Banerjee
Follow
353 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.39.3
x